Therapeutic Vision, Inc.
Biotech · Private
HK-2, an orally-administered multifunctional redox modulator that sequesters transition metals and quenches reactive oxygen species to prevent blast-induced hearing loss and cognitive decline
therapeuticvision.com →- Grants
- $985K
- 4 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 4
- 2 granted · 2 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20152016201720182019202020212022
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase II · Treatment of Canine Diabetic Cataracts | $498,270 | |
| Federal grant | Department of Health and Human Services · Phase II · Treatment of Canine Diabetic Cataracts | $186,734 | |
| Federal grant | Department of Health and Human Services · Phase I · Multifunctional Antioxidant to Prevent Noise-Induced Hearing Loss | $150,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Effect of Multifunctional Redox Modulator (MFRM) HK-2 on Acoustic Blast Overpressure and Cognitive Function | $149,949 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 3230 | KADVAX TECHNOLOGIES, INC. | — | — |
| 3231 | SONOVAL LLC | — | — |
| 3232 | ROSEBUD BIOSCIENCES INC. | — | — |
| 3233 | Therapeutic Vision, Inc. | — | — |
| 3234 | Florica Therapeutics, Inc. | — | — |
| 3235 | Inotrem | — | — |
| 3236 | EyeBio | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Method of Preventing Blast-Induced Loss of Cochlear and Vestibular Hair Cells and Auditory Spiral Ganglion Neuronsgranted
- Composition For Treating Ocular Effects Of Diabetesgranted
- Method of Preventing Blast-Induced Loss of Cochlear and Vestibular Hair Cells and Auditory Spiral Ganglion Neuronsapplication
- Method Of Preventing Blast-induced Loss Of Cochlear And Vestibular Hair Cells And Auditory Spiral Ganglion Neuronsapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.